One study from the Women’s Health Initiative presented results for estradiol with and without adjustment for free IGF-1 and insulin; positive associations with postmenopausal breast cancer appeared stronger with adjustment for both IGF-1 and insulin [40]. The gene discussed is IGF1; the disease is breast carcinoma.